Summary
Acetylcholinesterase (AChE), an enzyme responsible for the breakdown of acetylcholine, is found both in cholinergic and non-cholinergic neurons in the central nervous system. In addition to its role in the catabolism of acetylcholine, AChE have other functions in brain, e.g. in the processing of peptides and proteins, and in the modulation of dopaminergic neurons in the brain stem. Several clinical and experimental studies have investigated AChE in brain and cerebrospinal fluid (CSF) in aging and dementia. The results suggest that brain AChE and its molecular forms show interesting changes in dementia and aging. However, CSF-AChE activity is not a very reliable or sensitive marker of the integrity and function of cholinergic neurons in the basal forebrain complex. Additional work is needed to clarify the role of AChE abnormality in the formation of pathology changes in patients with Alzheimer's disease.
Similar content being viewed by others
References
Appleyard ME, Smith AD (1987) Spontaneous and carbachol-evoked in vivo secretion of acetylcholinesterase from the hippocampus of the rat. Neurochem Int 11: 397–406
Appleyard ME, Smith AD, Wilcock GK, Esiri MM (1983) Decreased CSF acetylcholinesterase activity in Alzheimer's disease. Lancet ii: 452
Appleyard ME, Smith AD, Berman P, Wilcock GK, Esiri MM, Neary D, Bowen DM (1987) Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Brain 110: 1309–1322
Appleyard ME, Vercher J-L, Greenfield SA (1988) Release of acetylcholinesterase from the guinea-pig cerebellum in vivo. Neuroscience 25: 133–138
Arendt T, Bigl V, Walther F, Sonntag M (1984) Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease. Lancet i: 173
Arendt T, Bigl V, Tennstedt A, Arendt A (1985) Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience 14: 1–14
Atack JR, Perry EK, Bonham JR, Perry RH, Tomlinson BE, Blessed G, Fairbarn A (1983) Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form. Neurosci Lett 40: 199–204
Atack JR, Perry EK, Bonham JR, Candy JM and Perry RH (1986) Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J Neurochem 47: 263–277
Atack JR, Perry EK, Bonham JR, Perry RH (1987a) Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid. J Neurochem 48: 1845–1850
Atack JR, Perry EK, Bonham JR, Candy JM (1987b) Loss and recovery of acetylcholinesterase molecular forms in the fornix-lesioned rat hippocampus. Neurosci Lett 79: 179–184
Atack JR, May C, Kaye JA, Kay AD, Rapoport SI (1988) Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type. Ann Neurol 23: 161–167
Aquilonius S-M, Eckernas S-Å (1975) Choline acetyltransferase in human cerebrospinal fluid: non-enzymatically and enzymatically catalyzed acetylcholine systhesis. J Neurochem 27: 317–318
Barth F, Ghandour MS (1983) Cellular localization of butyrylcholinesterase in adult rat cerebellum determined by immunofluorescence. Neurosci Lett 39: 149–153
Bareggi SR, Giacobini E (1978) Acetylcholinesterase activity in ventricular and cisternal CSF of dogs effects of chlorpromazine. J Neurosci Res 3: 335–339
Bartus RT, Dean RL (1987) Animal models for age-related memory disturbances. In: Coyle JT (ed) Animal models of dementia. Alan R Liss, New York, pp 69–79
Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–417
Beal MF, Martin JB (1986) Neuropeptides in neurological disease. Ann Neurol 20: 547–565
Biegon A, Greenberger V, Segal M (1986) Quantitative histochemistry of brain acetylcholinesterase in learning rate in the aged rat. Neurobiol Aging 7: 215–217
Bisso GM, Diana G, Meneguz A, Fortuna S, Michalek H (1987) Do basal forebrain lesions in the rat reproduce a selective loss of heavy (11S) molecular form of cortical acetylcholinesterase characteristic for Alzheimer's disease? In: Structural-functional properties of the basal forebrain cholinergic system. ESN-IBRO Satellite Symposium, Leipzig, GDR (Abstracts, p 8)
Bowen DM, Smith CP, White P, Davinson AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459–496
Bowen DM, Smith CB, White P, Goodhardt MJ, Spillane JA, Flack RHA, Davison AN (1977) Chemical pathology of the organic dementias. I. Validity of biochemical measurements in human post-mortem brain specimens. Brain 100: 397–426
Brimijoin S (1983) Molecular forms of acetylcholinesterase in brain, nerve, and muscle: nature, localization, and dynamics. Prog Neurobiol 21: 291–322
Brockman SK, Usiak MF, Younkin SG (1986) Assembly of monomeric acetylcholinesterase into tetrameric and asymmetric forms. J Biol Chem 261: 1201–1207
Carson KA, Geula C, Mesulam M-M (1991) Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue. Brain Res 540: 204–208
Catalan RE, Martinez AM, Aragones MD, Miguel BG, Robles A, Codoy JE (1984) Effects of substance P on acetylcholinesterase activity. Biochem Int 8: 203–208
Chubb IW, Smith AD (1975) Release of acetylcholinesterase into the perfusate from the ox adrenal gland. Proc Roy Soc Lond B 191: 263–269
Chubb IW, Millar TJ (1984) Is intracellular acetylcholinesterase involved in the processing of peptide neurotransmitters? Clin Exp Hypertens A6 (1 & 2): 79–89
Collerton D (1986) Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19: 1–28
Danielsson E, Eckernäs S-Å, Westlind-Danielsson A, Nordström Ö, Bartfai T, Gottfries C-G, Wallin A (1988) VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase in brain tissue affected by Alzheimer's disease/senile dementia of the Alzheimer type. Neurobiol Aging 9: 152–162
Davies P (1979) Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 171: 319–326
Davies P, Maloney AJ (1976) Selective loss of cholinergic neurons in Alzheimer's disease. Lancet ii: 1403
Decker MW (1987) The effects of aging on hippocampal and cortical projections of the forbrain cholinergic system. Brain Res Rev 12: 423–438
DeKosky ST, Hackney C, Scheff SW (1985) Acetylcholine (ACh) synthesis and endogenous choline acetyltransferase (CAT) inhibitory activity in human CSF. Neurology 35 [Suppl 1]: 258
Delfs JR, Zhu C-H, Dichter MA (1984) Coexistence of acetylcholinesterase and somatostatin-immunoreactivity in neurons cultured from rat cerebrum. Science 223: 61–63
Deutsch SI, Mohs RC, Levy MI (1983) Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer disease, and normals. Biol Psychiatry 18: 1363–1370
Direnfeld LK, Albert ML, Volicer L, Langlais PJ, Marquis J, Kaplan E (1984) Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings. Arch Neurol 41: 935–941
Drachman DA, Levitt J (1974) Human memory and the cholinergic system: a relationship with aging. Arch Neurol 30: 113–121
Dubois B, Ruberg M, Javoy-Agid F, Ploska A, Agid Y (1983) A subcortico-cortical cholinergic system is affected in Parkinson's disease. Brain Res 288: 213–218
Elble R, Giacobini E, Scarsella GF (1987) Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer's disease. Arch Neurol 44: 403–407
Elble R, Giacobini E, Higgins C (1989) Choline levels are increased in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging 10: 45–50
Fischer W, Gage FH, Björklund A (1989) Degenerative changes in forebrain cholinergic nuclei correlate with cognitive impairments in aged rats. Eur J Neurosci 1: 34–45
Fishman EB, Siek GC, MacCallum RD, Bird ED, Volicer L, Marquis JK (1986) Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Ann Neurol 19: 246–252
Gennari K, Brodbeck U (1985) Molecular forms of acetylcholinesterase from human caudate nucleus: comparisons of salt-soluble and detergent-soluble tetrameric enzyme species. J Neurochem 44: 697–704
Geula C, Mesulam M-M (1989a) Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res 498: 185–189
Geula C, Mesulam M-M (1989b) Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study. Neuroscience 33: 469–481
Giacobini E (1990) The cholinergic system in Alzheimer's disease. In: Aquillonius S-M, Gillberg P-G (eds) Cholinergic neurotransmission: functional and clinical aspects. Prog Brain Res 84: 321–332
Giacobini E, Becker R, Elble R, Mattio T, McIhany M (1986) Acetylcholine metabolism in brain. Is it reflected by CSF changes? In: Fischer A (ed) Alzheimer and Parkinson's diseases. Plenum Press, New York, pp 309–316
Gomez S, Davious P, Faivre-Bauman A, Valade D, Jeannin C, Rondot P, Puymirat J (1986) Acetylcholinesterase activity and somatostatin-like immunoreactivity in lumbar cerebrospinal fluid of demented patients. In: Fisher A (ed) Alzheimer and Parkinson's diseases. Plenum Press, New York, pp 317–322
Grassi J, Vigny M, Massoulie J (1982) Molecular forms of acetylcholinesterase in bovine caudate nucleus and superior cervical ganglion: solubility properties and hydrophobic character. J Neurochem 38: 457–469
Greenfield SA (1984) Acetylcholinesterase may have novel functions in the brain. Trends Neurosci 7: 364–368
Greenfield SA (1991) A noncholinergic action of acetylcholinesterase (AChE) in the brain: from neuronal secretion to the generation of movement. Cell Mol Neurobiol 11: 55–77
Greenfield SA, Smith AD (1979) The influence of electrical stimulation of certain brain areas on the concentration of acetylcholinesterase on rabbit cerebrospinal fluid. Brain Res 177: 445–459
Greenfield SA, Chubb IW, Smith AD (1979) The effect of chloropromazine on the concentration of acetylcholinesterase in the cerebrospinal fluid of rabbits. Neuropharmacology 18: 127–132
Greenfield SA, Appleyard ME, Bloomfield MR (1986) 6-Hydroxydopamine-induced turning behaviour in the rat: the significance of acetylcholinesterase in cerebrospinal fluid. Behav Brain Res 21: 47–54
Hammond P, Brimjoin S (1988) Acetylcholinesterase in Huntington's and Alzheimer's diseases: simultaneous enzyme assay and immunoassay of multiple brain regions. J Neurochem 50: 1111–1116
Hartikainen P, Reinikainen KJ, Sirviö J, Soikkeli R, Soininen H, Riekkinen PJ (1990) Neurotransmitter markers in the cerebrospinal fluid of normal aging subjects. J Neural Transm [GenSect] 84: 103–117
Hartikainen P, Reinikainen KJ, Soininen H, Sirviö J, Soikkeli R, Riekkinen PJ (1992) Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls. J Neurol Transm [P-D Sect] 4: 53–68
Henderson Z (1986) Is there a link between choline acetyltransferase-containing neurones and butyrylcholinesterase in rat cerebral cortex? Trends Neurosci 9: 20
Henderson Z (1989) Acetylcholinesterase on the dendrites of central cholinergic neurons: an electron microscopical study in the ferret. Neuroscience 28: 95–108
Henke H, Lang W (1983) Cholinergic enzymes in neocortex, hippocampus, and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Brain Res 267: 281–291
Hornykiewz O, Kish SJ (1986) Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45: 19–34
Huff FJ, Maire JC, Growdon JH, Corkin SH, Wurtman RJ (1985) CSF cholinesterase in Alzheimer's disease. Neurology 35: 218
Huff FJ, Maire JC, Growdon JH, Corkin S, Wurtman RJ (1986) Cholinesterases in cerebrospinal fluid correlation with clinical measures in Alzheimer's disease. J Neurol Sci 72: 121–129
Huff FJ, Reiter CT, Rosen J, Peters J, van Kammen DP (1988) No effect of haloperidol on cerebrospinal fluid acetylcholinesterase in patients with schizophrenia. Biol Psychiatry 24: 701–704
Hyman BT, Van Hoesen GW, Damasio AR (1987) Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 22: 37–40
Inestrosa NC, Roberts WL, Marshall TL, Rosenberry TL (1987) Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterase in other tissues. J Biol Chem 262: 4441–4444
Inestrosa NC, Perelman A (1989) Distribution and anchoring of molecular forms of acetylcholinesterase. Trends Pharmacol Sci 10: 325–329
Johnson D, Domino EF (1971) Cholinergic enzymatic activity of cerebrospinal fluid of patients with various neurologic diseases. Clin Chim Acta 35: 421–428
Jolkkonen JT, Soininen HS, Riekkinen PJ (1985) The effect of ACTH4-9 analog (Org 2766) on some cerebrospinal fluid parameters in patients with Alzheimer's disease. Life Sci 37: 585–590
Jolkkonen J, Soininen H, Halonen T, Ylinen A, Laulumaa V, Laakso M, Riekkinen P (1986) Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia. J Neurol Neurosurg Psychiatry 49: 1374–1377
Joo F, Csillik B (1966) Topographic correlation between the hematoencephalic barrier and the cholinesterase activity in brain capillaries. Exp Brain Res 1: 147–151
Kasa P (1986) The cholinergic systems in brain and spinal cord. Prog Neurobiol 26: 211–272
Katzman R (1986) Alzheimer's disease. N Engl J Med 314: 964–973
Koelle GB, Massoulie J, Eugene D, Melone MAB, Boulla G (1987) Distributions of molecular forms of acetylcholinesterase and butyrylcholinesterase in nervous tissue of the cat. Proc Natl Acad Sci (USA) 84: 7749–7752
Koponen H, Sirviö J, Reinikainen KJ, Riekiinen PJ (1991) A longitudinal study of cerebrospinal fluid acetylcholinesterase in delirium: changes at the acute stage and at one year follow-up. Psychiatry Res 38: 135–142
Kosik KS (1991) Alzheimer plaques and tangles: advances on both fronts. Trends Neurosci 14: 218–219
Kuhar MJ (1976) The anatomy of cholinergic neurons. In: Goldberg AM, Hanin I (eds) Biology of cholinergic functions. Raven Press, New York, pp 3–27
Kumar V, Giacobini E (1988) Cerebrospinal fluid choline, and acetylcholinesterase activity in familial vs. non-familial Alzheimer's disease patients. Arch Gerontol Geriatr 7: 111–117
Kumar V, Giacobini E, Markwell S (1989) CSF choline and acetylcholinesterase in earlyonset vs. late-onset Alzheimer's disease patients. Acta Neurol Scand 80: 461–466
Lal S, Wood PL, Kiely ME, Etienne P Gauthier S, Stratford J, Ford RM, Dastoor D, Nair NPV (1984) CSF acetylcholinesterase in dementia and in sequential samples of lumbar CSF. Neurobiol Aging 5: 269–274
Low MG, Futerman AH, Ackermann KE, Sherman WR, Silman I (1987) Removal of covalently bound inositol from torpedo acetylcholinesterase and mammalian alkaline phosphatases by deamination which nitrous acid. Biochem J 241: 615–619
Luine VN, Renner KJ, Heady S, Jones KJ (1986) Age and sex-dependent decreases in ChAT in basal forebrain nuclei. Neurobiol Aging 7: 193–198
MacDonald E, Sirviö J (1992) Neurotoxins as tools in lesioning experiments. In: Harvey AL (ed) Neuroscience perspective series — natural and synthetic neurotoxins. Academic Press, London (in press)
Mackay AVP, Davies P, Dewar AJ, Yates CM (1978) Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain. J Neurochem 30: 827–829
Main AR (1976) Structure and inhibitors of cholinesterase. In: Goldberg AM, Hanin I (eds) Biology of cholinergic function. Raven Press, New York, pp 269–353
Manyam BV, Giacobini E, Colliver JA (1990) Cerebrospinal fluid choline levels are decreased in Parksinon's disease. Ann Neurol 27: 683–685
Marquis JK, Volicer L, Mark KA, Direnfeld LK, Freedman M (1985) Cholinesterase activity in plasma, erythrocytes, and cerebrospinal fluid of patients with dementia of the Alzheimer type. Biol Psychiatry 20: 605–610
Massoulie J, Bon S (1982) The molecular forms of cholinesterase and acetylcholinesterase in vertebrates. Annu Rev Neurosci 5: 57–106
May C, Kaye JA, Atack JR, Schapiro MB, Friedland RP, Rapoport SI (1990) Cerebrospinal fluid production is reduced in healthy aging. Neurology 40: 500–503
Mesulam M-M, Moran MA (1987) Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease. Ann Neurol 22: 223–228
Mesulam M-M, Geula C (1988) Acetylcholinesterase-rich pyramidal neurons in the human neocortex and hippocampus: absence at birth, development during the life span, and dissolution in Alzheimer's disease. Ann Neurol 24: 765–773
Mesulam M-M, Mufson EJ, Wainer BH, Levey AI (1983) Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10: 1185–1201
Michalek H, Fortuna S, Pintor A (1989a) Age-related differences in brain choline acetyltransferase, cholinesterases and muscarinic receptor sites in two strains of rats. Neurobiol Aging 10: 143–148
Michalek H, Meneguz A, Volpe MT, Bisso GM (1989b) Acetylcholinesterase molecular forms as markers of rat brain physiological aging. Abstracts of the 12th Annual Meeting of the European Neuroscience Association. Eur J Neurosci [Suppl 2]: 140
Mohan C, Radha E (1978) Age dependent kinetic changes in the activities of central cholinergic enzymes. Exp Gerontol 13: 349–356
Muller F, Dumez Y, Massoulie J (1985) Molecular forms and solubility of acetylcholinesterase during the embryonic development of rat and human brain. Brain Res 331: 295–302
Nakamura S, Vincent SR (1985) Acetylcholinesterase and somatostatin immunoreactivity coexist in human neocortex. Neurosci Lett 61: 183–187
Nakano S, Kato T, Nakamura S, Kameyama M (1986) Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia. J Neurol Sci 75: 213–223
Navaratnam DS, Priddle JD, McDonald B, Esiri MM, Robinson JR, Smith AD (1991) Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease. Lancet 337: 447–450
Page KJ, Everitt BJ, Robbins TW, Marston HM, Wilkinson LS (1991) Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA-and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss. Neuroscience 43: 457–472
Payner TD, Drake RL, Saker DM, Shipley MT (1987) Determination of molecular forms of brain acetylcholinesterase: technical considerations. Brain Res Bull 19: 287–290
Pearlson GD, Tune LE (1986) Cerebral ventricular size and cerebrospinal fluid acetylcholinesterase levels in senile dementia of the Alzheimer type. Psychiatry Res 17: 23–29
Perry EK (1980) The cholinergic system in old age and Alzheimer's disease. Age Ageing 9: 1–8
Perry EK (1986) The cholinergic hypothesis—ten years on. Br Med Bull 42: 63–69
Perry EK, Perry RH (1981) Brain biochemistry in dementia of Alzheimer-type. In: Rose FC (ed) Metabolic disorders of the nervous system. Pitman, London, pp 382–417
Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet i: 289
Perry EK, Atack JR, Perry RH, Hardy JA, Dodd PR, Edwardson JA, Blessed G, Tomlinson BE, Fairbarn AF (1984) Intralaminar neurochemical distributions in human midtemporal cortex: comparison between Alzheimer's disease and the normal. J Neurochem 42: 1402–1410
Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbarn A, Tomlinson BE, Perry RH (1985) Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 48: 413–421
Pope A, Hess HH, Lewin E (1965) Microchemical pathology of the cerebral cortex in presenile dementia. Trans Am Neurol Assoc 89: 15–16
Price DL (1986) New perspectives on Alzheimer's disease. Ann Rev Neurosci 9: 489–512
Quinn NP, Rossor MN, Marsden CD (1986) Dementia and Parkinson's disease —pathological and neurochemical considerations. Br Med Bull 42: 86–90
Rakonczay Z (1988) Cholinesterase and its molecular forms in pathological states. Prog Neurobiol 31: 311–330
Rakonczay Z, Kása P, Sirviö J, Riekkinen PJ (1989) Activity and molecular forms of cerebrospinal fluid acetylcholinesterase in normal aging Alzheimer's disease and amyotrophic lateral sclerosis. Eur J Neurosci [Suppl 2]: 238
Reinikainen K (1988) Neurotransmitters in Alzheimer's disease. Series reports, no 9, Department of Neurology, University of Kuopio
Reinikainen KJ, Riekkinen PJ, Paljärvi L, Soininen H, Helkala E-L, Jolkkonen J, Laakso M (1988) Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data. Neurochem Res 13: 135–146
Reinikainen KJ, Soininen H, Riekkinen PJ (1990) Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy. J Neurosci Res 27: 576–586
Riekkinen PJ, Soininen H, Sirviö J, Reinikainen K, Helkala E-L, Paljärvi L (1987) Dementia without cholinergic deficit. Gerontology 33: 268–272
Riekkinen P jr, Miettinen R, Rummukainen J, Pitkänen A, Paljärvi L, Riekkinen P (1990a) The effects of lesioning the basal forebrain cholinergic neurones on CSF AChE activity. Neurosci Res Commun 6: 37–43
Riekkinen P Jr, Sirviö J, Riekkinen P (1990b) Similar memory impairments found in medial septal-vertical diagonal band of Broca and nucleus basalis lesioned rats: are memory defects induced by nucleus basalis lesions related to the degree of non-specific subcortical cell loss? Behav Brain Res 37: 81–88
Riekkinen PJ, Buzsaki G, Riekkinen P Jr, Soininen H, Partanen J (1991) The cholinergic system and EEG slow waves. Electroencephalogr Clin Neurophysiol 78: 89–96
Rinne UK, Riekkinen P, Sonninen V, Laaksonen H (1973) Brain acetylcholinesterase in Parkinson's disease. Acta Neurol Scand 49: 215–226
Rinne UK, Rinne JO, Rinne JK, Laakso K (1987) Chemical neurotransmission in the parkinsonian brain. Med Biol 65: 75–81
Robertson RT, Lieu CL, Lee K, Gorenstein C (1986) Distribution of “non-specific” cholinesterase-containing neurons in the dorsal thalamus of the rat. Brain Res 368: 116–124
Rosenberry Tl, Chen YT, Bock E (1974) Structure of 11S acetylcholinesterase. Subunit composition. Biochemistry 13: 3068–3079
Ruberg M, Rieger F, Villageois A, Bonnet AM, Agid Y (1986) Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and nondemented patients with Parkinson's disease. Brain Res 362: 83–91
Ruberg M, Villageois A, Bonnet A-M, Pillon B, Rieger F, Agid Y (1987) Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems. J Neurol Neurosurg Psychiatry 50: 538–543
Scarsella G, Toschi G, Bareggi SR, Giacobini E (1979) Molecular forms of cholinesterases in cerebrospinal fluid, blood plasma, and brain tissue of the beagle dog. J Neurosci Res 4: 19–24
Schegg KM, Gillespie RP, Peacock JH (1990) Changes in membrane-bound and soluble molecular forms of acetylcholinesterase in mouse hippocampus after cholinergic denervation. Neurosci Lett 118: 197–200
Schätz CR, Geula C, Mesulam M-M (1990) Competetive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease. Neurosci Lett 117: 56–61
Shimon M, Egozi Y, Kloog Y, Sokolovsky M, Cohen S (1989) Vascular cholinesterase and choline uptake in isolation of rat forebrain microvessels. A possible link. J Neurochem 53: 561–565
Shute CCD, Lewis PR (1963) Cholinesterase-containing systems of the brain of the rat. Nature 199: 1160–1164
Silver A (1974) The biology of cholinesterases. North-Holland/Elsevier, Amsterdam
Sims NR, Bowen DM, Allen SJ, Smith CCT, Neary D, Thomas DJ, Davison AN (1983) Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 40: 503–509
Sirviö J, Soininen HS, Kutvonen R, Hyttinen J-M, Helkala E-L, Riekkinen PJ (1987) Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci 81: 273–279
Sirviö J, Valjakka A, Jolkkonen J, Hervonen A, Riekkinen PJ (1988a) Cholinergic enzyme activities and muscarinic binding in the cerebral cortex of rats of different age and sex. Comp Biochem Physiol 90C: 245–248
Sirviö J, Hervonen A, Valjakka A, Riekkinen PJ (1988b) Pre- and postsynaptic markers of cholinergic neurons in the cerebral cortex of rats of different ages. Exp Gerontol 23: 473–479
Sirviö J, Kutvonen R, Soininen H, Hartikainen P, Riekkinen PJ (1989a) Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease. J Neural Transm 75: 119–127
Sirviö J, Rinne JO, Valjakka A, Rinne UK, Riekkinen PJ, Paljärvi L (1989 b) Different forms of brain acetylcholinesterase and muscarinic binding in Parkinson's disease. J Neurol Sci 90: 23–32
Sirviö J, Pitkänen A, Pääkkönen A, Partanen J, Riekkinen PJ (1989 c) Brain cholinergic enzymes and cortical EEG activity in young and old rats. Comp Biochem Physiol 94C: 277–283
Sirviö J, Riekkinen PJ, Hervonen A (1989d) Age-dependence of the solubility fractions of acetylcholinesterase in the cerebral cortex and cerebellum of the rat. Neurosci Lett 96: 218–222
Sirviö J, Rakonczay Z, Hartikainen P, Kasa P, Riekkinen PJ (1991) The molecular forms of acetylcholinesterase in cerebrospinal fluid of normal subjects — effect of aging. J Neural Transm [GenSect] 86: 147–150
Small DH (1990) Non-cholinergic actions of acetylcholinesterases: proteases regulating cell growth and development? TiBS 15: 213–216
Small DH, Ismael Z, Chubb IW (1987) Acetylcholinesterase exhibits trypsin-like and metalloexopeptidase-like activity in cleaving a model peptide. Neuroscience 21: 991–995
Small DH, Moir RD, Fuller SJ, Michaelson S, Bush AI, Li Q-X, Milward E, Hilbich C, Weidemann A, Beyreuther K, Masters CL (1991) A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease. Biochemistry 30: 10795–10799
Smith AD, Cuello AC (1984) Alzheimer's disease and acetylcholinesterase-containing neurons. Lancet i: 513
Smith G (1988) Animal models of Alzheimer's disease: experimental cholinergic denervation. Brain Res Rev 13: 103–118
Soininen H, Halonen T, Riekkinen PJ (1981) Acetylcholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand 64: 217–224
Soininen HS, Jolkkonen JT, Reinikainen KJ, Halonen T, Riekkinen PJ (1984a) Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of Alzheimer type. J Neurol Sci 63: 167–172
Soininen H, Pitkänen A, Halonen T, Riekkinen PJ (1984b) Dopamine-β-hydroxylase and acetylcholinesterase activities in cerebrospinal fluid in Alzheimer's disease. Acta Neurol Scand 69: 29–34
Sung SC, Ruff BA (1983) Molecular forms of sucrose extractable and particulate acetylcholinesterase in the developing and adult rat brain. Neurochem Res 8: 303–311
Szilágyi AK, Németh A, Martini E, Lendvai B, Venter V (1987) Serum and CSF cholinesterase activity in various kinds of dementia. Eur Arch Psychiatr Neurol Sci 236: 309–311
Taylor P, Schumacher M, Maulet Y, Newton M (1986) A molecular perspective on the polymorphism of acetylcholinesterase. Trends Pharmacol Sci 7: 321–323
Thal LJ (1985) Changes in cerebrospinal fluid associated with dementia. Ann NY Acad Sci 444: 235–241
Tsim KWK, Randall WR, Barnard EA (1988) An asymmetric form of muscle acetylcholinesterase contains three subunit types and two enzymic activities in one molecule. Proc Natl Acad Sci (USA) 85: 1262–1266
Tune L, Gucker S, Folstein M, Oshida L, Coyle JT (1985) Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type. Ann Neurol 17: 46–48
Urakami K, Adachi Y, Awaki E, Takahashi K (1989) Characterization of the course of senile dementia of the Alzheimer type using cerebrospinal fluid levels of acetylcholinesterase and somatostatin. Acta Neurol Scand 80: 232–237
Wester P, Eriksson S, Forsell Å, Puu G, Adolfsson R (1988) Monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of progressive dementia patients: relation to clinical parameters. Acta Neurol Scand 77: 12–21
Weston J, Greenfield SA (1986) Release of acetylcholinesterase in the rat nigrostriatal pathway: relation to receptor activation and firing rate. Neuroscience 17: 1079–1088
Whitehouse PJ, Struble RG, Hedren JC, Clark AW, Price DL (1985) Alzheimer's disease and related dementia: selective involvement of specific neuronal systems. Crit Rev Clin Neurobiol 1: 319–339
Wood PL, Etienne P, Lal S, Gauthier S, Cajal S, Nair NPV (1982) Reduced lumbar CSF somatostatin levels in Alzheimer's disease. Life Sci 31: 2073–2079
Yates CM, Simpson J, Gordon A, Maloney AFJ, Allison Y, Ritchie JM, Urquhart A (1983) Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome. Brain Res 280: 119–126
Younkin SG, Goodridge B, Katz J, Lockett G, Nafziger D, Usiak MF, Younkin LH (1986) Molecular forms of acetylcholinesterases in Alzheimer's disease. Fed Proc 45: 2982–2988
Zigmond MJ, Stricker EM, Berger TW (1987) Parkinsonism: Insights from animal models utilizing neurotoxic agents. In: Coyle JT (ed) Animal models of dementia. Alan R Liss, New York
Zubenko GS, Marquis JK, Volicer L, Direnfeld LK, Langlais PJ, Nixon RA (1986) Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study. Biol Psychiatry 21: 1365–1381
Zubenko GS, Moossy J, Hanin I, Martinez J, Rao GR, Kopp U (1988) Bilateral symmetry of cholinergic deficits in Alzheimer's disease. Arch Neurol 45: 255–259
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sirviö, J., Riekkinen, P.J. Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies. J Neural Transm Gen Sect 4, 337–358 (1992). https://doi.org/10.1007/BF02260081
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02260081